Fran Cook-Bolden is a Dermatology physician affiliated with Cornell University. OpenAlex indexes 77 publications with 2,238 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
150 E 58th St
3rd Floor Annex
New York, NY 101550002
Telephone
212-223-6599Registry record last updated 7 Apr 2009.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Botanix SB IncProgram year202510 payments
- ABBVIE INC.Program year20255 payments
- LEO Pharma Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
37%Corticosteroid16.7%Halobetasol Propionate49%Triamcinolone Acetonide37%Fluocinolone Acetonide14%Part D≥32 patientsalpha-Hydroxy Acid14.9%Ammonium Lactate100%Part D≥51 patients+ 1 more class in this area
Sensory organs
22.4%Corticosteroid22.4%Clobetasol Propionate66%Hydrocortisone26%Betamethasone Dipropionate8%Part D<11 patientsAnti-infectives
10.7%Lincosamide Antibacterial4.6%Clindamycin Phosphate100%Part D≥17 patientsTetracycline-class Drug4.2%Doxycycline Hyclate59%Doxycycline Monohydrate41%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Guidelines of care for the management of acne vulgaris
Journal of the American Academy of Dermatology
2024 - Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin
Journal of Dermatological Treatment
2022 - Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Adult Age Groups
Journal of Drugs in Dermatology
2022 - Efficacy and Safety of Tazarotene 0.045% Lotion in Caucasian Adults With Moderate-to-Severe Acne
Journal of Drugs in Dermatology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Devereux, MD
Cornell University
Thomas Walsh, MD
Cornell University
Cora Sternberg, MD
Cornell University
George Alexopoulos, MD
Cornell University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”